NYC-based FCB Health appointed Kim Barke to the role of group creative director to lead its oncology accounts.

Remedy Pharmaceuticals announced that Biogen completed an asset purchase of its Phase 3 candidate, Cirara.

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration approved Kalydeco (ivacaftor) for use in people with cystic fibrosis ages 2 and older who have one of 23 residual function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

X-Chem announced a collaboration with Vertex for the discovery of small-molecule leads against validated targets for severe, genetic diseases.

Influencer marketing done right can make a big splash.

Mesmerize Marketing, an established leader in patient education at the point of care (POC) since 2006, announced that it acquired Elite Sampling & Media Group’s national network of doctors’ office wallboards.

Fitbit, the leader in connected health and fitness wearables, for this first time identified its list of Fittest Countries as well as the Fittest Cities in the United States.

John Mangano was named senior VP, Strategy and Analytics, at Digitas Health – the Agency of Now.

Symphony Health’s new Audience & Media division will provide data-driven insights vital to healthcare marketers.

The healthcare communications agency Discovery Worldwide announced the appointment of Matt Silver to SVP, Strategy, Engagement and Analytics.